An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Neuroendocrine Tumour (NET) With Carcinoid Syndrome
Both
Neuroendocrine Tumour (NET) With Carcinoid Syndrome
Trial Information
An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
Inclusion Criteria:
- Out-patients 18 years of age and older, who have agreed to participate in the study
- Diagnosed with a Neuroendocrine tumour (NET) and receiving treatment with Somatuline
Autogel
Exclusion Criteria:
- Subjects for whom there are reasons that may hinder the conduct of the study
(patients who have difficulty expressing themselves or who are unable to complete the
questionnaires, or with insufficient data in the their files will not be enrolled in
the study).
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Cross-Sectional
Outcome Measure:
Subject's overall satisfaction regarding control of diarrhea
Outcome Description:
Use of questionnaires to assess patient satisfaction (Likert scale).
Outcome Time Frame:
Day of survey
Safety Issue:
No
Principal Investigator
Christine Massien, MD
Investigator Role:
Study Director
Investigator Affiliation:
Ipsen
Authority:
United Kingdom: National Health Service
Study ID:
8-79-52030-736
NCT ID:
NCT01234168
Start Date:
October 2010
Completion Date:
December 2012
Related Keywords:
- Neuroendocrine Tumour (NET) With Carcinoid Syndrome
- Carcinoid Tumor
- Diarrhea
- Malignant Carcinoid Syndrome
- Serotonin Syndrome
- Neuroendocrine Tumors
Name | Location |
|---|
